On November 7, 2024, amended the credit agreement with OrbiMed in a mutually beneficial arrangement, forgoing access to an additional $50 million in funding in exchange for removal of the 12-month ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback